CKD Bio Corp. Logo

CKD Bio Corp.

Develops and manufactures probiotics & APIs using fermentation, also offering cGMP CMO services.

063160 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 서대문구 충정로 8, 서울특별시
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

CKD Bio Corp. is a biopharmaceutical company specializing in the development and manufacturing of probiotics and active pharmaceutical ingredients (APIs). Leveraging over 50 years of expertise in fermentation technology and chemical synthesis, the company's core activities include the production of fermentation-based APIs, such as antibiotics, ß-lactamase inhibitors, and immunosuppressants. It also focuses on the research and development of next-generation probiotics through its dedicated microbiome research division. Additionally, CKD Bio provides Contract Manufacturing Organization (CMO) services for APIs and intermediates, utilizing its cGMP-certified production facilities. The company manages a fully integrated process from microbial strain development and fermentation to purification and final synthesis, aiming for global leadership in biotechnology.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-17 00:00
Regulatory News Service
투자판단관련주요경영사항
Korean 7.4 KB
2025-08-14 00:00
Interim Report
반기보고서 (2025.06)
Korean 912.4 KB
2025-07-25 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.2 KB
2025-05-15 00:00
Quarterly Report
분기보고서 (2025.03)
Korean 968.8 KB
2025-04-25 00:00
Earnings Release
영업(잠정)실적(공정공시)
Korean 13.2 KB
2025-04-09 00:00
Regulatory News Service
투자판단관련주요경영사항 (티엠버스주200단위(클로스트리디움보툴리눔독소A형)제조판매 품목허가 신청)
Korean 14.0 KB
2025-04-01 00:00
Regulatory News Service
투자판단관련주요경영사항 (티엠버스주100단위(클로스트리디움보툴리눔독소A형) 제조판매 품목허가 승인)
Korean 7.5 KB
2025-03-26 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 18.6 KB
2025-03-18 00:00
Audit Report / Information
감사보고서제출
Korean 11.3 KB
2025-03-18 00:00
Annual Report
사업보고서 (2024.12)
Korean 1.3 MB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 7.1 KB
2025-02-25 00:00
Notice of Dividend Amount
현금ㆍ현물배당결정
Korean 8.8 KB
2025-02-25 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 111.3 KB
2025-02-25 00:00
Proxy Solicitation & Information Statement
의결권대리행사권유참고서류
Korean 89.4 KB
2025-01-24 00:00
Regulatory News Service
매출액또는손익구조30%(대규모법인은15%)이상변경
Korean 11.8 KB

Automate Your Workflow. Get a real-time feed of all CKD Bio Corp. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for CKD Bio Corp. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.